AVS Bio (Arlington Capital Partners platform) Acquires Biorbyt Ltd.

September 23, 2026

AVS Bio, a portfolio company of Arlington Capital Partners, announced it has acquired Biorbyt Ltd., a global supplier of bio-reagents and related biomaterials for life science research. The acquisition is intended to expand AVS Bio’s biomaterials catalog and add Biorbyt’s advanced ecommerce platform to improve global distribution capabilities.

Buyers
AVS Bio, Arlington Capital Partners
Targets
Biorbyt Ltd.
Platforms
AVS Bio
Industry
Biotechnology
Location
United Kingdom
Transaction Type
Buyout

Explore More

Related articles

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.

Find buyers like these →